| Target Price | CHF234.09 |
| Price | CHF194.00 |
| Potential |
20.66%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target HBM Healthcare Investments 2026 .
The average HBM Healthcare Investments target price is CHF234.09.
This is
20.66%
register free of charge
CHF247.80
27.73%
register free of charge
CHF225.23
16.10%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend HBM Healthcare Investments to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the HBM Healthcare Investments stock has an average upside potential 2026 of
20.66%
register free of charge
|
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million CHF | 42.01 | 35.80 |
| 81.16% | 14.78% | |
| Net Margin | 44.13% | 23.22% |
| 1,047.62% | 47.39% |
3 Analysts have issued a sales forecast HBM Healthcare Investments 2026 . The average HBM Healthcare Investments sales estimate is
This results in the following potential growth metrics:
3 HBM Healthcare Investments Analysts have issued a net profit forecast 2026. The average HBM Healthcare Investments net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 2.72 | 1.24 |
| 1,800.00% | 54.41% | |
| P/E | 155.90 | |
| EV/Sales | 39.22 |
3 Analysts have issued a HBM Healthcare Investments forecast for earnings per share. The average HBM Healthcare Investments EPS is
This results in the following potential growth metrics and future valuations:
HBM Healthcare Investments...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Aug 05 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jan 19 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Oct 20 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Aug 05 2025 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 18 2025 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Jan 19 2025 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Oct 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


